A Prospective, Multi-center, Randomized Trial To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization

Trial Profile

A Prospective, Multi-center, Randomized Trial To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Arsenic trioxide (Primary) ; Sirolimus
  • Indications Cardiovascular disorders; Coronary artery restenosis
  • Focus Adverse reactions
  • Acronyms PERFECT-II
  • Sponsors Beijing AmsinoMed Medical Device Co
  • Most Recent Events

    • 24 Jun 2017 Planned End Date changed from 1 Aug 2020 to 1 Aug 2022.
    • 21 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top